<?xml version="1.0" encoding="UTF-8"?>
<glossary>
 <title>Abbreviations</title>
 <def-list>
  <def-item>
   <term>HIV</term>
   <def>
    <p id="Par5">Human immunodeficiency virus</p>
   </def>
  </def-item>
  <def-item>
   <term>PDR</term>
   <def>
    <p id="Par6">Pretreatment drug resistance</p>
   </def>
  </def-item>
  <def-item>
   <term>PLWHA</term>
   <def>
    <p id="Par7">People living with HIV or AIDS</p>
   </def>
  </def-item>
  <def-item>
   <term>UNAIDS</term>
   <def>
    <p id="Par8">United Nations programme on HIV/AIDS</p>
   </def>
  </def-item>
  <def-item>
   <term>WHO</term>
   <def>
    <p id="Par9">World Health Organization</p>
   </def>
  </def-item>
  <def-item>
   <term>ART</term>
   <def>
    <p id="Par10">Antiretroviral therapy</p>
   </def>
  </def-item>
  <def-item>
   <term>ARV</term>
   <def>
    <p id="Par11">Antiretroviral virus</p>
   </def>
  </def-item>
  <def-item>
   <term>NFATP</term>
   <def>
    <p id="Par12">National Free Antiretroviral Treatment Program</p>
   </def>
  </def-item>
  <def-item>
   <term>NNRTI</term>
   <def>
    <p id="Par13">Non-nucleoside reverse-transcriptase inhibitor</p>
   </def>
  </def-item>
  <def-item>
   <term>NRTI</term>
   <def>
    <p id="Par14">Nucleoside reverse-transcriptase inhibitor</p>
   </def>
  </def-item>
  <def-item>
   <term>PI</term>
   <def>
    <p id="Par15">Protease inhibitor</p>
   </def>
  </def-item>
  <def-item>
   <term>IDUs</term>
   <def>
    <p id="Par16">Injected drug users</p>
   </def>
  </def-item>
  <def-item>
   <term>PMTCT</term>
   <def>
    <p id="Par17">Prevention of mother-to-child transmission</p>
   </def>
  </def-item>
  <def-item>
   <term>PrEP</term>
   <def>
    <p id="Par18">Pre-exposure prophylaxis</p>
   </def>
  </def-item>
  <def-item>
   <term>EFV</term>
   <def>
    <p id="Par19">Efavirenz</p>
   </def>
  </def-item>
  <def-item>
   <term>NVP</term>
   <def>
    <p id="Par20">Nevirapine</p>
   </def>
  </def-item>
  <def-item>
   <term>FTC</term>
   <def>
    <p id="Par21">Emtricitabine</p>
   </def>
  </def-item>
  <def-item>
   <term>3TC</term>
   <def>
    <p id="Par22">Lamivudine</p>
   </def>
  </def-item>
  <def-item>
   <term>ABC</term>
   <def>
    <p id="Par23">Abacavir</p>
   </def>
  </def-item>
  <def-item>
   <term>DDI</term>
   <def>
    <p id="Par24">Didanosine</p>
   </def>
  </def-item>
  <def-item>
   <term>D4T</term>
   <def>
    <p id="Par25">Stavudine</p>
   </def>
  </def-item>
  <def-item>
   <term>TDF</term>
   <def>
    <p id="Par26">Tenofovir</p>
   </def>
  </def-item>
  <def-item>
   <term>AZT</term>
   <def>
    <p id="Par27">Azidothymidine</p>
   </def>
  </def-item>
  <def-item>
   <term>DRV/r</term>
   <def>
    <p id="Par28">Darunavir</p>
   </def>
  </def-item>
  <def-item>
   <term>LPV/r </term>
   <def>
    <p id="Par29">Lopinavir</p>
   </def>
  </def-item>
  <def-item>
   <term>ATV/r</term>
   <def>
    <p id="Par30">Atazanavir</p>
   </def>
  </def-item>
  <def-item>
   <term>DRM</term>
   <def>
    <p id="Par31">Drug resistance mutation</p>
   </def>
  </def-item>
  <def-item>
   <term>HIVDR</term>
   <def>
    <p id="Par32">HIV Drug Resistance Database</p>
   </def>
  </def-item>
  <def-item>
   <term>TN93</term>
   <def>
    <p id="Par33">Tamuraâ€“Nei 93</p>
   </def>
  </def-item>
  <def-item>
   <term>
    <italic>OR</italic>
   </term>
   <def>
    <p id="Par34">Odds ratio</p>
   </def>
  </def-item>
  <def-item>
   <term>a
    <italic>OR</italic>
   </term>
   <def>
    <p id="Par35">Adjusted odds ratio</p>
   </def>
  </def-item>
  <def-item>
   <term>
    <italic>CI</italic>
   </term>
   <def>
    <p id="Par36">Confidence interval</p>
   </def>
  </def-item>
 </def-list>
</glossary>
